US FDA approves Urogen's bladder cancer drug

The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday.
This article was produced by Reuters news agency. It has not been edited by Global South World.